Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diastolic dysfunction in congestive heart failure.

J A Johnson1

  • 1Department of Clinical Pharmacy, University of Tennessee, Memphis 38163.

Clinical Pharmacy
|November 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Visceral fat and race-dependent health risks in obese nondiabetic premenopausal women.

Diabetes·1997
Same author

Translocation inhibitors define specificity of protein kinase C isoenzymes in pancreatic beta-cells.

The Journal of biological chemistry·1997
Same author

Advanced cement technique improves fixation in elbow arthroplasty.

Clinical orthopaedics and related research·1997
Same author

Vibrio cholerae O1 can assume a chlorine-resistant rugose survival form that is virulent for humans.

The Journal of infectious diseases·1996
Same author

An improved permeabilization protocol for the introduction of peptides into cardiac myocytes. Application to protein kinase C research.

Circulation research·1996
Same author

Five primary synchronous neoplasms of the gastrointestinal tract.

Journal of clinical gastroenterology·1996

Diastolic dysfunction, a key factor in heart failure with preserved ejection fraction, requires specific therapeutic strategies. Certain medications may help, while others, like digitalis glycosides, could be harmful.

Area of Science:

  • Cardiology
  • Heart Failure Research

Background:

  • Congestive heart failure (CHF) affects millions globally.
  • A significant subset of CHF patients exhibit normal systolic function.
  • Diastolic dysfunction is increasingly recognized as a primary cause in these patients.

Purpose of the Study:

  • To review the evaluation of diastolic function.
  • To highlight the significance of diastolic dysfunction in CHF.
  • To examine the impact of various therapeutic agents on diastolic dysfunction.

Main Methods:

  • Literature review and synthesis.
  • Analysis of existing studies on cardiac function and therapeutic interventions.
  • Comparison of clinical presentations and treatment responses.

Related Experiment Videos

Main Results:

  • Diastolic dysfunction underlies 30-40% of CHF cases with normal systolic function.
  • Left ventricular hypertrophy and ischemic heart disease are primary causes.
  • Clinical presentations of diastolic and systolic dysfunction-induced CHF are similar.
  • Diuretics, vasodilators, ACE inhibitors, beta-agonists, and PDE III inhibitors may benefit patients.
  • Digitalis glycosides may be detrimental; beta-blockers show neutral effects on diastolic function.

Conclusions:

  • Diastolic dysfunction is a critical determinant of CHF.
  • Tailored therapeutic approaches are necessary for diastolic dysfunction-related CHF.
  • Further research is needed to fully understand diastolic dysfunction and its management.